1 October 2022

37th Process Development Symposium

Organised by:

SCI's Fine Chemicals Group

Cambridge, UK

Registration Closed

This event is no longer available for registration.


This page is a test page for a website update. Please do NOT register for this event. Thank you.


Process Development is the application of chemistry to the scale up of new synthetic processes from the laboratory, through pilot plant to full-scale commercial manufacture and into life cycle management. It is an extremely broad discipline, crossing the boundaries between synthetic organic chemistry, process technology and chemical engineering. The area of Process Development continues to be a challenging and important area for the research into and application of modern synthetic organic chemistry, as well as enabling technologies.


The symposium aims to bring together a wide range of speakers from across the Pharmaceutical, Agrochemical and Fine Chemical industries, as well as from an academic background. This meeting brings together experts from across the entire spectrum of the discipline to present state-of-the-art process development. As an established and well attended meeting, the process development symposium offers an excellent opportunity for networking between like-minded process scientists of all levels of experience and from all areas of the chemical industry.

Wednesday 25 March
Registration and refreshments
Lunch and exhibition

CHAIRPERSON: Stella James, Bionow, UK
Opening remarks

Engineering Approaches in Pharmaceutical Chemical Process Development 
Dr Suju Matthew, Pfizer, UK

Davis oxaziridines: development and applicationse
Laurent Petit, Minakem, Belgium
Experimental design and its place in process development
Laura Forfar, Catalysis Consulting Ltd, UK
Refreshment break and exhibition

CHAIRPERSON: David Lathbury, Astute Chemical Development Consulting Ltd, UK
Probing reagent / catalyst (dis)function
Guy Lloyd Jones, University of Edinburgh, UK
Process development of a robust manufacturing route for bridion
Sue Zultanski, MSD, USA
Closing remarks
Wine reception sponsored by Chiralquest
Dinner for residents
Thursday 26 March
CHAIRPERSON: Max Espensen, Pharmaron, UK
Site-Specific and Enantioselective sp3 C-H Functionalization
Prof Guosheng Liu, SIOC, China (remote presentation)
Application of transition-metal catalysis, biocatalysis and flow chemistry as state-of-the-art technologies in the synthesis of LCZ696
Florian Kleinbeck, Novartis, Switzerland
Refreshment break and exhibition
CHAIRPERSON: Hazmi Tajuddin, Syngenta, UK
Automation and autonomy to enable process chemistry
Jason Hein, University of British Columbia, Canada
Process development in the synthesis of CF corrector VX-661
Christian Harrison, Vertex, USA
Lunch and exhibition

CHAIRPERSON: Andy Wells, Charnwood Technical Consulting, UK
An enantioselective total synthesis of (+)-duocarmycin SA
Michael Schmidt, Bristol-Myers Squibb, USA
Racing to the finish: the benefit of 3D printed flow reactors in scale-up
Lana Borukhova, Innosyn, The Netherlands
The application of C-H functionalisation in the development of a concise and convergent route to nemiralisib
Katherine Wheelhouse, GlaxoSmithKline, UK
Refreshment break and exhibition

CHAIRPERSON: David Lathbury, Astute Chemical Development Consulting Ltd, UK
Right particle journey: crystallisation process development from labs to scale to support drug product processing
Rachel Sullivan, AstraZeneca, UK
Process chemistry award winner 2019
Prof Ross Denton, University of Nottingham, UK
Closing remarks
Wine reception sponsored by Johnson Matthey
Conference dinner

Friday 27 March
CHAIRPERSON: David Pascoe, GlaxoSmithKline, UK
New perspectives: approaches for the application of metal scavengers to impurity control in pharma
Sunil Rana, Biotage GB, UK
Processing of high-aspect ratio particles
Frans L. Muller, University of Leeds
Refreshment break and exhibition
CHAIRPERSON: Rob Walton, Pfizer, UK
Particle design and modelling technologies for API manufacturing
Claire Wombwell, Johnson Matthey, UK
Solvent selection methods and tool
Julia Baumeister, Syngenta, UK
Closing remarks

Venue and Contact

Churchill College

Storey’s Way                         


Conference Team

Tel: +44 (0)20 7598 1561

Email: conferences@soci.org


Early bird fees before Friday 31 January 2020

£380 SCI Member
£260 SCI Subsidised Member
£425 Non-Member

Standard fees after Friday 31 January 2020

£495 SCI Member
£290 SCI Subsidised Member
£550 Non-Member

SCI Platinum Corporate Members receive 25% off the above rates.

Accommodation Fees

£162 Standard Accommodation
£203 Ensuite Accommodation

Accommodation can be booked for delegates at the college in single study ensuite or standard bedrooms. Bedrooms will be allocated on a first come, first served basis.The accommodation package is for 2 nights - Wednesday 25 and Thursday 26 March and includes full English or Continental breakfast.

Rooms must be vacated by 10.00am on the day of departure.

You will have the opportunity to book this as part of the online booking process when you register for the event.

Please note: Bedrooms at the college will be available from 14.00 on the day of arrival. Those not wishing to stay in college accommodation can book accommodation directly through www.visitcambridge.org.

Student Bursaries

A limited number of student bursaries are available to registered participants, as a contribution to the cost of registration fees, travel or accommodation. To receive an application form and for more information, please email conferences@soci.org

Become an SCI Member and save on this and future events

See Membership Options

Sign up as an Event Member to join this event. SCI Full or Student Members receive discounts on event registrations

Booking Process/Deadlines

Booking terms and conditions

CPD Info

SCI Members attending this meeting are able to claim CPD points.

Accredited cpd event - The CPD Standards Office

Additional Info

Organising committee

  • Louis Diorazio, SCI/AstraZeneca

  • Max Espensen, Pharmaron

  • Stella James, SCI/Bionow

  • Dave Lathbury, SCI/Astute Chemical Development Ltd

  • David Pascoe, SCI/GlaxoSmithKline

  • Hazmi Tajuddin, SCI/Syngenta

  • Robert Walton, SCI/Pfizer

  • Andy Wells, Charnwood Technical Consulting Ltd 


An exhibition will run alongside the conference during refreshment breaks, for companies and related organisations who may wish to exhibit.  For further information and prices please email jacqui.maguire@soci.org